BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30992323)

  • 1. ROCK Inhibition Induces Terminal Adipocyte Differentiation and Suppresses Tumorigenesis in Chemoresistant Osteosarcoma Cells.
    Takahashi N; Nobusue H; Shimizu T; Sugihara E; Yamaguchi-Iwai S; Onishi N; Kunitomi H; Kuroda T; Saya H
    Cancer Res; 2019 Jun; 79(12):3088-3099. PubMed ID: 30992323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of cancer stem cells by differentiation therapy.
    Arima Y; Nobusue H; Saya H
    Cancer Sci; 2020 Aug; 111(8):2689-2695. PubMed ID: 32462706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis.
    Shimizu T; Ishikawa T; Sugihara E; Kuninaka S; Miyamoto T; Mabuchi Y; Matsuzaki Y; Tsunoda T; Miya F; Morioka H; Nakayama R; Kobayashi E; Toyama Y; Kawai A; Ichikawa H; Hasegawa T; Okada S; Ito T; Ikeda Y; Suda T; Saya H
    Oncogene; 2010 Oct; 29(42):5687-99. PubMed ID: 20676132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma.
    Le Nail LR; Brennan M; Rosset P; Deschaseaux F; Piloquet P; Pichon O; Le Caignec C; Crenn V; Layrolle P; Hérault O; De Pinieux G; Trichet V
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29494553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
    Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
    Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity.
    Gatti M; Solari A; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Würth R; Corsaro A; Bajetto A; Ratto A; Ferrari A; Daga A; Barbieri F; Florio T
    Exp Cell Res; 2018 Feb; 363(1):48-64. PubMed ID: 29305964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
    Xia Y; Cai X; Fan J; Zhang L; Li Z; Ren J; Wu G; Zhu F
    Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potential.
    Sette G; Salvati V; Memeo L; Fecchi K; Colarossi C; Di Matteo P; Signore M; Biffoni M; D'Andrea V; De Antoni E; Canzonieri V; De Maria R; Eramo A
    PLoS One; 2012; 7(10):e46891. PubMed ID: 23056514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cells in osteosarcoma.
    Brown HK; Tellez-Gabriel M; Heymann D
    Cancer Lett; 2017 Feb; 386():189-195. PubMed ID: 27894960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line.
    Martins-Neves SR; Lopes ÁO; do Carmo A; Paiva AA; Simões PC; Abrunhosa AJ; Gomes CM
    BMC Cancer; 2012 Apr; 12():139. PubMed ID: 22475227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors.
    Dani N; Olivero M; Mareschi K; van Duist MM; Miretti S; Cuvertino S; Patané S; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF
    J Bone Miner Res; 2012 Jun; 27(6):1322-34. PubMed ID: 22367914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRM270 inhibits cancer stem cell maintenance via microRNA regulation in chemoresistant A549 lung adenocarcinoma cells.
    Kwon T; Chandimali N; Huynh DL; Zhang JJ; Kim N; Bak Y; Yoon DY; Yu DY; Lee JC; Gera M; Ghosh M; Park YH; Jeong DK
    Cell Death Dis; 2018 Feb; 9(2):244. PubMed ID: 29445170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct conversion of osteosarcoma to adipocytes by targeting TNIK.
    Hirozane T; Masuda M; Sugano T; Sekita T; Goto N; Aoyama T; Sakagami T; Uno Y; Moriyama H; Sawa M; Asano N; Nakamura M; Matsumoto M; Nakayama R; Kondo T; Kawai A; Kobayashi E; Yamada T
    JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33400690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimethyloxalylglycine Promotes Bone Marrow Mesenchymal Stem Cell Osteogenesis via Rho/ROCK Signaling.
    Zhang L; Jiang G; Zhao X; Gong Y
    Cell Physiol Biochem; 2016; 39(4):1391-403. PubMed ID: 27606625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor β1 signal is crucial for dedifferentiation of cancer cells to cancer stem cells in osteosarcoma.
    Zhang H; Wu H; Zheng J; Yu P; Xu L; Jiang P; Gao J; Wang H; Zhang Y
    Stem Cells; 2013 Mar; 31(3):433-46. PubMed ID: 23225703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle enhanced combination therapy for stem-like progenitors defined by single-cell transcriptomics in chemotherapy-resistant osteosarcoma.
    Wang L; Huang X; You X; Yi T; Lu B; Liu J; Lu G; Ma M; Zou C; Wu J; Zhao W
    Signal Transduct Target Ther; 2020 Sep; 5(1):196. PubMed ID: 32973147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
    Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
    Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.
    Wang T; Wang D; Zhang L; Yang P; Wang J; Liu Q; Yan F; Lin F
    J Exp Clin Cancer Res; 2019 May; 38(1):226. PubMed ID: 31138318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.